Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
about
Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitopeConstitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model
P2860
Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@en
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@nl
type
label
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@en
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@nl
prefLabel
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@en
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@nl
P2093
P2860
P356
P1433
P1476
Vaccination with a fusion prot ...... ral challenge by vaccinia-gag.
@en
P2093
Cindi-Ann Williams
Francesca N Raffa
Geoffrey W Stone
James M Termini
Sachin Gupta
P2860
P304
P356
10.1128/JVI.02229-13
P407
P577
2013-11-13T00:00:00Z